(Q33948551)

30 July 2017

1 reference

title

Cancer anorexia and cachexia (English)

1 reference

30 July 2017

Tisdale MJ

1

1 reference

30 July 2017

language of work or name

1 reference

1 May 2001

1 reference

30 July 2017

1 reference

30 July 2017

volume

17

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

438-442

1 reference

Symptoms potentially influencing weight loss in a cancer population. Correlations with primary site, nutritional status, and chemotherapy administration

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Body cell mass in cancer-bearing and anorexic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

The Sir David Cuthbertson Medal Lecture 1991. The mechanisms and treatment of weight loss in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Abnormalities of taste sensation in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Refractory hypothalamic adenylate cyclase in anorectic tumor-bearing rats: implications for NPY-induced feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Assessment of feeding response of tumor-bearing rats to hypothalamic injection and infusion of neuropeptide Y

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorectic tumor-bearing rats

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Cracking the riddle of cancer anorexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Interleukin-1-induced anorexia in the rat. Influence of prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. The response to glucose infusion and parenteral feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Fatty acid mobilization and glucose metabolism in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Catabolism of adipose tissue by a tumour-produced lipid-mobilising factor

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Characterization of differentiation factor/leukaemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Increased expression of the mRNA for hormone-sensitive lipase in adipose tissue of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Brown adipose tissue in cancer patients: possible cause of cancer-induced cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Intralipid infusion combined with propranolol administration has favorable metabolic effects in elderly malnourished cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Brown adipose tissue, beta 3-adrenergic receptors, and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Cancer cachexia and protein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Protein synthesis in muscle measured in vivo in cachectic patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Depressed protein synthesis is the dominant characteristic of muscle wasting and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Role of the calpain system in muscle growth

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Mechanism of muscle protein degradation induced by a cancer cachectic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Acute treatment with tumour necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

TNF Can Directly Induce the Expression of Ubiquitin-Dependent Proteolytic System in Rat Soleus Muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Skeletal muscle myocytes undergo protein loss and reactive oxygen‐mediated NF‐κB activation in response to tumor necrosis factorα

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Different cytokines modulate ubiquitin gene expression in rat skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

The relationship between weight loss and interleukin 6 in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Bioactivity of skeletal muscle proteolysis-inducing factors in the plasma proteins from cancer patients with weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Mechanism of muscle protein degradation in cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Characterization of a cancer cachectic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Structural analysis of a tumor-produced sulfated glycoprotein capable of initiating muscle protein degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Induction of muscle protein degradation by a tumour factor

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361).

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Effect of a cachectic factor on carbohydrate metabolism and attenuation by eicosapentaenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Inhibition of tumour-induced lipolysis in vitro and cachexia and tumour growth in vivo by eicosapentaenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900506-8

7 January 2021

10.1016/S0899-9007(01)00506-8

Identifiers

DOI

1 reference

release_v7dukxiewfhh5dcllxhxvqrzwy

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v7dukxiewfhh5dcllxhxvqrzwy

24 November 2022

mapped directly with Wikidata item

1 reference